Analysis of Proinflammatory Factors in the Synovial Fluid In Patients With Rotator Cuff Disease
1 other identifier
observational
40
0 countries
N/A
Brief Summary
Role of proinflammatory factors in Patients with Rotator Cuff Disease Objective: To measure the levels of various cytokines and metalloproteases in patients with rotator cuff disease, and control group and to determine the correlations among them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2010
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2010
CompletedFirst Posted
Study publicly available on registry
February 17, 2010
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedFebruary 17, 2010
February 1, 2010
1 year
February 9, 2010
February 16, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cytokines and MMP's levels in patients with RC pathology and in control group
12 month
Secondary Outcomes (1)
Levels of pain curve by using Visual Analogue Scale
12 month
Study Arms (2)
RC tear
This study will include a consecutive series of patients who met the study inclusion criteria. Study group patients will be diagnosed RC tear on clinical examination and imaging findings (US and MRI) that will be verified at arthroscopy in order to complete the enrollment.
Control group
Control group will include patients suffering from shoulder instability that scheduled for elective surgical repair.
Eligibility Criteria
This study will include a consecutive series of patients who met the study inclusion criteria. Study group patients will be diagnosed RC tear on clinical examination and imaging findings (US and MRI) that will be verified at arthroscopy in order to complete the enrollment. Control group will include patients suffering from shoulder instability that scheduled for elective surgical repair.
You may qualify if:
- Ability to understand and accept the trial procedures and to sign an informed consent form in accordance with national legislation.
- Patients between age 18-65 scheduled for a surgery in a Shoulder unit
- Patients suffering from Rotator Cuff Disease
- Patients suffering from any noninflammatory shoulder condition which requires surgical intervention
You may not qualify if:
- Revision rotator cuff repair
- Recurrent shoulder surgery
- Psychiatric illness
- Inflammatory condition.
- Current use of anti-inflammatory drugs.
- Previous or current shoulder infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Synovial fluid lavages will be collected at the time of arthroscopic RC reconstruction or other shoulder arthroscopy that will be performed for therapeutic goals (instability repair, SLAP lesion).
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
February 9, 2010
First Posted
February 17, 2010
Study Start
March 1, 2010
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
February 17, 2010
Record last verified: 2010-02